Design Therapeutics Inc. (DSGN)

AI Score

Unlock

3.98

0.10 (2.58%)

At close: Apr 28, 2025, 1:00 PM

Design Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	22.56M	30.33M	45.7M	29.4M	21.2M	27.94M	27.2M	28.81M	26.5M	42.52M	119.65M	287.31M	298.57M	357.66M	370.84M	400.69M	2.38M	-77K
Short-Term Investments	222.91M	223.75M	215.32M	241.29M	260.6M	263M	275.89M	286.58M	303.89M	301.72M	239.72M	83.91M	85.5M	36.06M	32M	10.65M	33.71M	154K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	239.72M	n/a	85.5M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	427K	427K	429K	427K	430K	437K	444K	452K	459K	466K	-239.25M	n/a	-85.5M	n/a	n/a	n/a	212K	-77K
Receivables	1.26M	n/a	1.4M	1.68M	1.43M	1.21M	994K	974K	1.11M	746K	691K	100K	110K	47K	76K	27K	10K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-1.21M	-994K	-974K	-1.11M	n/a	1.42M	2.44M	-110K	n/a	n/a	n/a	107K	n/a
Other Current Assets	n/a	1.18M	n/a	n/a	n/a	3.6M	2.96M	3.55M	n/a	n/a	236K	112K	n/a	n/a	n/a	n/a	25K	n/a
Total Current Assets	248.04M	257.24M	264.84M	273.89M	284.58M	294.54M	306.05M	318.94M	335.12M	348.49M	361.72M	373.87M	385.44M	395.29M	404.88M	411.75M	36.23M	77K
Property-Plant & Equipment	3.63M	3.96M	4.31M	4.48M	4.63M	4.89M	5.14M	5.35M	5.56M	5.62M	5.74M	4.93M	5.12M	5.06M	271K	100K	71K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.05M	4.39M	4.74M	4.91M	5.06M	5.33M	5.58M	5.8M	6.02M	6.08M	6.21M	4.93M	5.12M	5.06M	271K	100K	283K	-77K
Total Assets	252.09M	261.63M	269.58M	278.79M	289.64M	299.87M	311.63M	324.74M	341.14M	354.57M	367.93M	378.8M	390.56M	400.35M	405.15M	411.85M	36.52M	n/a
Account Payables	2.19M	1.47M	1.3M	1.37M	1.94M	2.21M	1.92M	2.74M	3.02M	2.62M	2.07M	1.9M	1.62M	2.22M	1.58M	2.03M	1.4M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-697K	-677K	n/a	n/a	n/a	n/a	n/a	-2.11M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.58M	2.99M	1.95M	2.92M	2.93M	5.42M	7.12M	3.85M	3.57M	4.47M	2.8M	1.63M	1.02M	1.4M	879K	1.26M	565K	n/a
Total Current Liabilities	8.46M	7.43M	6.39M	7.09M	9.62M	12.39M	12.13M	9.05M	10.78M	10.41M	7.39M	5.48M	5.28M	5.5M	3.4M	3.71M	2.33M	n/a
Long-Term Debt	n/a	n/a	1.95M	n/a	2.33M	2.52M	2.7M	2.88M	3.05M	3.22M	3.38M	3.01M	3.14M	3.27M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-1.95M	n/a	-2.33M	-2.52M	-2.7M	-2.88M	-3.05M	-3.22M	-3.38M	-3.01M	-3.14M	-3.26M	140K	142K	45.5M	n/a
Total Long-Term Liabilities	1.53M	1.74M	1.95M	2.14M	2.33M	2.52M	2.7M	2.88M	3.05M	3.22M	3.38M	3.01M	3.14M	3.28M	140K	142K	45.5M	n/a
Total Liabilities	10M	9.18M	8.34M	9.24M	11.96M	14.91M	14.84M	11.93M	13.83M	13.63M	10.77M	8.49M	8.43M	8.79M	3.54M	3.85M	47.83M	n/a
Total Debt	2.33M	2.52M	2.7M	2.88M	3.05M	3.22M	3.38M	2.88M	3.69M	3.84M	3.98M	3.52M	3.63M	3.75M	n/a	n/a	n/a	n/a
Common Stock	6K	6K	6K	6K	6K	6K	6K	6K	6K	6K	6K	6K	6K	6K	6K	6K	1K	n/a
Retained Earnings	-227.21M	-213.56M	-200.52M	-188.73M	-177.63M	-165.78M	-150M	-130.06M	-110.76M	-93.42M	-75.72M	-60.72M	-47.46M	-36.39M	-25.07M	-17.44M	-11.92M	n/a
Comprehensive Income	475K	914K	-217K	-167K	62K	-1.28M	-2M	-1.98M	-3.36M	-3.86M	-2.31M	-1.32M	-244K	-4K	-12K	2K	156K	-3.64M
Shareholders Equity	242.1M	252.45M	261.24M	269.56M	277.69M	284.96M	296.8M	312.82M	327.31M	340.94M	357.16M	370.31M	382.13M	391.56M	401.6M	408.01M	-11.31M	-3.64M
Total Investments	222.91M	223.75M	215.32M	241.29M	260.6M	263M	275.89M	286.58M	303.89M	301.72M	479.45M	83.91M	85.5M	36.06M	32M	10.65M	33.71M	154K